Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung

Respirology

Volumn 18, Issue 8, 2013, Pages 1191-1196

  Antoniou, Katerina M ^a   Walsh, Simon L ^b   Hansell, David M ^b   Rubens, Michael R ^b   Marten, Katharina ^e   Tennant, Rachel ^b   Hansel, Trevor ^b   Desai, Sujal R ^c   Siafakas, Nikolaos M ^f   Du Bois, Roland M ^d   Wells, Athol U ^a  

^a Interstitial Lung Disease Unit   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f UNIVERSITY OF CRETE   (Greece)

Author keywords

emphysema; idiopathic pulmonary fibrosis; pathogenesis; rheumatoid lung; smoking

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG DISEASE; LUNG EMPHYSEMA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATIC LUNG DISEASE; SMOKING;

EMPHYSEMA; IDIOPATHIC PULMONARY FIBROSIS; PATHOGENESIS; RHEUMATOID LUNG; SMOKING;

AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; EMPHYSEMA; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LOGISTIC MODELS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84886826413     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12154     Document Type: Article

References (34)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of COPD: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-555.
2. Agusti A, Thomas A,. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease. Proc. Am. Thorac. Soc. 2006; 3: 478-481.
3. Sopori M,. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2002; 2: 372-376.
4. Klareskog L, Padyukov L, Alfredsson L,. Smoking as a trigger for inflammatory rheumatic diseases. Curr. Opin. Rheumatol. 2007; 19: 49-54.
5. Wells AU, Nicholson AG, Hansell DM,. Challenges in pulmonary fibrosis. 4: smoking-induced diffuse interstitial lung diseases. Thorax 2007; 62: 904-910.
6. Marten K, Milne D, Antoniou KM, et al. Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur. Radiol. 2009; 19: 1679-1685.
7. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N. Engl. J. Med. 2011; 304: 807-906.
8. Cottin V, Nunes H, Brillet PY, et al.; Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586-593.
9. Cottin V, Nunes H, Mouthon L, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum. 2011; 63: 295-304.
10. Brown KK,. Rheumatoid lung disease. Proc. Am. Thorac. Soc. 2007; 4: 443-448.
11. Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005; 127: 2019-2027.
12. Antoniou KM, Hansell DM, Rubens MB, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am. J. Respir. Crit. Care Med. 2008; 177: 190-194.
13. Vuorinen K, Ohlmeier S, Leppäranta O, et al. Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis. J. Histochem. Cytochem. 2008; 56: 951-959.
14. Volonte D, Kahkonen B, Shapiro S, et al. Caveolin-1 expression is required for the development of pulmonary emphysema through activation of the ATM-p53-p21 pathway. J. Biol. Chem. 2009; 284: 5462-5466.
15. Bringardner BD, Baran CP, Eubank TD, et al. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid. Redox Signal. 2008; 10: 287-301.
16. Suzuki M, Betsuyaku T, Ito Y, et al. Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009; 296: L614-623.
17. Koli K, Myllärniemi M, Keski-Oja J, et al. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid. Redox Signal. 2008; 10: 333-342.
18. Antoniou KM, Alexandrakis MG, Siafakas NM, et al. Cytokine network in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2005; 22: 91-104.
19. Plataki M, Tzortzaki E, Rytila P, et al. Apoptotic mechanisms in the pathogenesis of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2006; 1: 161-171.
20. Antoniou KM, Pataka A, Bouros D, et al. Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 2007; 20: 453-461.
21. Löfdahl JM, Wahlström J, Sköld CM,. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin. Exp. Immunol. 2006; 145: 428-437.
22. Veeraraghavan S, Latsi PI, Wells AU, et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur. Respir. J. 2003; 22: 239-244.
23. Zandvoort A, Postma DS, Jonker MR, et al. Smad gene expression in pulmonary fibroblasts: indications for defective ECM repair in COPD. Respir. Res. 2008; 9: 83.
24. Gauldie J, Kolb M, Ask K, et al. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc. Am. Thorac. Soc. 2006; 3: 696-702.
25. Greene CM, Low TB, O'Neill SJ, et al. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. Am. J. Respir. Crit. Care Med. 2010; 181: 31-35.
26. Rinaldi M, Lehouck A, Heulens N, et al. Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease. Thorax 2012; 67: 694-700.
27. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann. Rheum. Dis. 2003; 62: 835-841.
28. Padyukov L, Silva C, Stolt P, et al. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004; 50: 3085-3092.
29. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006; 54: 38-46.
30. Bongartz T, Cantaert T, Atkins SR, et al. Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology 2007; 46: 70-75.
31. Aubart F, Crestani B, Nicaise-Roland P, et al. High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis. J. Rheumatol. 2011; 38: 979-982.
32. De Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007; 132: 1932-1938.
33. Smith BM, Pinto L, Ezer N, et al. Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis. Lung Cancer 2012; 77: 58-63.
34. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am. J. Respir. Crit. Care Med. 2003; 167: 962-969.